company background image
PRGO logo

Perrigo NYSE:PRGO Stock Report

Last Price

US$32.19

Market Cap

US$4.3b

7D

1.9%

1Y

-9.1%

Updated

28 Mar, 2024

Data

Company Financials +

PRGO Stock Overview

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally.

PRGO fundamental analysis
Snowflake Score
Valuation6/6
Future Growth3/6
Past Performance0/6
Financial Health3/6
Dividends4/6

Perrigo Company plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Perrigo
Historical stock prices
Current Share PriceUS$32.19
52 Week HighUS$40.28
52 Week LowUS$25.77
Beta0.62
1 Month Change17.91%
3 Month Change0.031%
1 Year Change-9.07%
3 Year Change-20.87%
5 Year Change-34.81%
Change since IPO176.90%

Recent News & Updates

Benign Growth For Perrigo Company plc (NYSE:PRGO) Underpins Its Share Price

Mar 27
Benign Growth For Perrigo Company plc (NYSE:PRGO) Underpins Its Share Price

Recent updates

Benign Growth For Perrigo Company plc (NYSE:PRGO) Underpins Its Share Price

Mar 27
Benign Growth For Perrigo Company plc (NYSE:PRGO) Underpins Its Share Price

These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively

Feb 01
These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively

The Market Doesn't Like What It Sees From Perrigo Company plc's (NYSE:PRGO) Revenues Yet

Dec 28
The Market Doesn't Like What It Sees From Perrigo Company plc's (NYSE:PRGO) Revenues Yet

Perrigo's New Chapter: Its Bold Turnaround Plan Is Worth Buying

Nov 15

The Prognosis For Perrigo

Aug 30

Perrigo Outlook Healed By Repositioning

Jun 12

Perrigo raises dividend by 5% to $0.273/share

Feb 21

Perrigo: Still Languishing But Short-Term Trend Offers Encouragement

Jan 18

Perrigo Non-GAAP EPS of $0.56 misses by $0.11, revenue of $1.1B misses by $40M, lowers FY adj. EPS guidance

Nov 08

Perrigo to invest $170M to expand baby formula manufacturing, buys Nestlé Gateway plant

Nov 01

Perrigo Company plc Is Back On Track

Oct 20

Perrigo to face FDA AdCom meeting for OTC contraceptive

Sep 12

Perrigo responds to 'misleading and inaccurate information' on Zantac claims

Aug 17

Perrigo reports Q2 mixed results; raises FY22 organic net sales growth outlook

Aug 09

Perrigo declares $0.26 dividend

Aug 02

Perrigo: HRA Acquisition To Drive Significant Growth

Jul 20

Perrigo unit seeks FDA over-the-counter approval for birth control pill Opill

Jul 11

Perrigo: The Longer The Base The Higher In Space

Apr 12

The Prognosis For Perrigo

Jan 09

Perrigo: Honing In On A Long Term Bottom

Dec 16

Perrigo Company plc (NYSE:PRGO) Shares Could Be 39% Below Their Intrinsic Value Estimate

Oct 17
Perrigo Company plc (NYSE:PRGO) Shares Could Be 39% Below Their Intrinsic Value Estimate

Perrigo: HRA Acquisition Is A Step In The Right Direction, But Fundamental Concerns Remain

Sep 24

Here's Why Perrigo (NYSE:PRGO) Has A Meaningful Debt Burden

Jul 13
Here's Why Perrigo (NYSE:PRGO) Has A Meaningful Debt Burden

Perrigo Company (PRGO) Presents At Evercore ISI Consumer & Retail Virtual Summit Conference - Slideshow

Jun 21

Are Investors Undervaluing Perrigo Company plc (NYSE:PRGO) By 44%?

Jun 21
Are Investors Undervaluing Perrigo Company plc (NYSE:PRGO) By 44%?

Perrigo Q1 2021 Earnings Preview

May 10

Perrigo - Simplifying To Unlock Appeal

May 02

Perrigo (NYSE:PRGO) Seems To Use Debt Quite Sensibly

Apr 12
Perrigo (NYSE:PRGO) Seems To Use Debt Quite Sensibly

Perrigo Company plc (NYSE:PRGO) Goes Ex-Dividend Soon

Mar 06
Perrigo Company plc (NYSE:PRGO) Goes Ex-Dividend Soon

Is There An Opportunity With Perrigo Company plc's (NYSE:PRGO) 35% Undervaluation?

Mar 04
Is There An Opportunity With Perrigo Company plc's (NYSE:PRGO) 35% Undervaluation?

Shareholder Returns

PRGOUS PharmaceuticalsUS Market
7D1.9%1.2%0.4%
1Y-9.1%25.8%28.8%

Return vs Industry: PRGO underperformed the US Pharmaceuticals industry which returned 23.9% over the past year.

Return vs Market: PRGO underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is PRGO's price volatile compared to industry and market?
PRGO volatility
PRGO Average Weekly Movement5.6%
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: PRGO has not had significant price volatility in the past 3 months.

Volatility Over Time: PRGO's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
18879,140Patrick Lockwood-Taylorhttps://www.perrigo.com

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Perrigo Company plc Fundamentals Summary

How do Perrigo's earnings and revenue compare to its market cap?
PRGO fundamental statistics
Market capUS$4.26b
Earnings (TTM)-US$4.40m
Revenue (TTM)US$4.66b

0.9x

P/S Ratio

-991.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PRGO income statement (TTM)
RevenueUS$4.66b
Cost of RevenueUS$2.98b
Gross ProfitUS$1.68b
Other ExpensesUS$1.68b
Earnings-US$4.40m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.032
Gross Margin36.09%
Net Profit Margin-0.094%
Debt/Equity Ratio85.4%

How did PRGO perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

-3,358%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.